13F filerCIK 1747057 ↗

D1 Capital Partners

You are looking at Q4 2024. See the latest, Q3 2026 →

Reported value

$6.02B

+16% on the quarter before

Positions

35

16 new, 15 sold out

Top 10

59.4%

of the value

Est. gain

+$121.7M

on stocks held all quarter

Est. return

+3.6%

on those stocks since Q3 2024

Filed

Feb 14, 2025

On SEC EDGAR ↗

Positions as of Dec 31, 2024, from D1 Capital Partners's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2024. Striped tiles are options.

Maplebear Inc16%
11 others11%
Philip Morris Intl Inc7.3%
Royal Caribbean Group6.0%
Constellation Brands Inc5.6%
Elevance Health Inc4.9%
Entegris4.5%GE HealthCare4.5%
Xpo Inc4.4%
Lineage Inc3.7%
3m Co2.9%
Charles Riv Labs Intl Inc2.9%
AppLovin2.6%
Nu Hldgs Ltd2.6%
Meta2.5%
Spotify Technology S A2.4%
Live Nation Entertainment In2.2%
Warby Parker Inc2.1%
Synopsys2.0%
Restaurant Brands Intl Inc1.9%
Bath & Body Works Inc1.8%
PTC1.8%
Toll Brothers Inc1.8%
Vistra1.5%Amazon1.5%

Largest buys

Since Q3 2024, sized at quarter-end prices.

  1. Elevance Health Inc~$294.8MNew, 0.0% → 4.9% of the portfolio+799,000 shares
  2. Constellation Brands Inc~$219.8MAdded, 2.7% → 5.6% of the portfolio+994,639 shares
  3. Entegris~$209.2MAdded, 1.4% → 4.5% of the portfolio+2,111,801 shares
  4. 3m Co~$175.1MNew, 0.0% → 2.9% of the portfolio+1,356,493 shares
  5. Charles Riv Labs Intl Inc~$172.8MNew, 0.0% → 2.9% of the portfolio+935,820 shares
  6. Lineage Inc~$158.3MAdded, 1.6% → 3.7% of the portfolio+2,703,598 shares
  7. AppLovin~$155.8MNew, 0.0% → 2.6% of the portfolio+481,000 shares
  8. Nu Hldgs Ltd~$154.2MNew, 0.0% → 2.6% of the portfolio+14,885,000 shares
  9. Synopsys~$122.8MNew, 0.0% → 2.0% of the portfolio+253,000 shares
  10. Bath & Body Works Inc~$109.8MNew, 0.0% → 1.8% of the portfolio+2,832,000 shares

Largest sells

Since Q3 2024, sized at quarter-end prices.

  1. Xpo Inc~$351.1MCut, 9.8% → 4.4% of the portfolio−2,677,204 shares
  2. Amazon~$176.0MCut, 4.4% → 1.5% of the portfolio−802,000 shares
  3. Bank America Corp~$174.9MSold out, 3.4% → 0.0% of the portfolio−4,406,706 shares
  4. Spotify Technology S A~$124.4MCut, 4.3% → 2.4% of the portfolio−278,000 shares
  5. Hdfc Bank Ltd~$120.4MSold out, 2.3% → 0.0% of the portfolio−1,924,045 shares
  6. Starbucks Corp~$116.2MSold out, 2.2% → 0.0% of the portfolio−1,192,028 shares
  7. Block~$109.6MSold out, 2.1% → 0.0% of the portfolio−1,632,342 shares
  8. Live Nation Entertainment In~$106.7MCut, 3.9% → 2.2% of the portfolio−823,904 shares
  9. Viking Holdings Ltd~$90.2MSold out, 1.7% → 0.0% of the portfolio−2,586,161 shares
  10. Mastec Inc~$81.8MSold out, 1.6% → 0.0% of the portfolio−664,828 shares

Holdings

As of Dec 31, 2024; changes in shares since Sep 30, 2024.

Positions, sorted by share of the portfolio
HoldingValue
Maplebear IncCOM · shares 0% · price +1.7%15.5%$934.1M+$15.3M
Philip Morris Intl IncCOM · shares +10% · price −0.9%7.3%$436.9M−$3.5M
Royal Caribbean GroupCOM · shares 0% · price +30.1%6.0%$362.2M+$83.7M
Constellation Brands IncCL A · shares +187% · price −14.2%5.6%$337.6M−$19.6M
Elevance Health IncCOM · shares New4.9%$294.8M—
EntegrisCOM · shares +329% · price −12.0%4.5%$272.7M−$8.6M
GE HealthCareCOMMON STOCK · shares +22% · price −16.7%4.5%$272.6M−$44.8M
Xpo IncCOM · shares −57% · price +22.0%4.4%$266.7M+$48.1M
Lineage IncCOM · shares +257% · price −25.3%3.7%$219.8M−$20.8M
3m CoCOM · shares New2.9%$175.1M—
Charles Riv Labs Intl IncCOM · shares New2.9%$172.8M—
AppLovinCOM CL A · shares New2.6%$155.8M—
Nu Hldgs LtdORD SHS CL A · shares New2.6%$154.2M—
MetaCL A · shares +0.2% · price +2.3%2.5%$147.7M+$3.3M
Spotify Technology S ASHS · shares −46% · price +21.4%2.4%$146.0M+$25.7M
Live Nation Entertainment InCOM · shares −45% · price +18.3%2.2%$130.1M+$20.1M
Warby Parker IncCL A COM · shares −33% · price +48.3%2.1%$127.4M+$41.5M
SynopsysCOM · shares New2.0%$122.8M—
Restaurant Brands Intl IncCOM · shares +33% · price −9.6%1.9%$115.3M−$9.2M
Bath & Body Works IncCOM · shares New1.8%$109.8M—
PTCCOM · shares +26% · price +1.8%1.8%$108.3M+$1.5M
Toll Brothers IncCOM · shares New1.8%$106.4M—
VistraCOM · shares New1.5%$92.6M—
AmazonCOM · shares −66% · price +17.7%1.5%$89.8M+$13.5M
Lennar CorpCL A · shares +67% · price −30.1%1.5%$88.1M−$22.7M
Total 35 positions100%$6.02B+$121.7M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2024 to Q4 2024: 19 stocks held throughout, up $121.7M (+3.6%).

  1. Royal Caribbean Group+$83.7M+30%
  2. Xpo Inc+$48.1M+22%
  3. Warby Parker Inc+$41.5M+48%
  4. Spotify Technology S A+$25.7M+21%
  5. Live Nation Entertainment In+$20.1M+18%
  6. Restaurant Brands Intl Inc−$9.2M−10%
  7. Constellation Brands Inc−$19.6M−14%
  8. Lineage Inc−$20.8M−25%
  9. Lennar Corp−$22.7M−30%
  10. GE HealthCare−$44.8M−17%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$40.00B$20.00B$0
Q4 2018Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$31.82B−9%SEC ↗
Q2 2026$34.78B+210%SEC ↗
Q1 2026$11.23B+5%SEC ↗
Q4 2025$10.70B+23%SEC ↗
Q3 2025$8.71B+21%SEC ↗
Q2 2025$7.20B+10%SEC ↗
Q1 2025$6.53B+8%SEC ↗
Q4 2024$6.02B+16%SEC ↗
Q3 2024$5.18B−13%SEC ↗
Q2 2024$5.93B−10%SEC ↗
Q1 2024$6.58B+16%SEC ↗
Q4 2023$5.69B−18%SEC ↗
Q3 2023$6.94B+34%SEC ↗
Q2 2023$5.20B−2%SEC ↗
Q1 2023$5.31B+9%SEC ↗
Q4 2022$4.88B−11%SEC ↗
Q3 2022$5.48B+30%SEC ↗
Q2 2022$4.22B−50%SEC ↗
Q1 2022$8.49B−49%SEC ↗
Q4 2021$16.55B−7%SEC ↗
Q3 2021$17.88B+17%SEC ↗
Q2 2021$15.30B+13%SEC ↗
Q1 2021$13.51B−36%SEC ↗
Q4 2020$21.19B+24%SEC ↗
Q3 2020$17.08B+27%SEC ↗
Q2 2020$13.41B+39%SEC ↗
Q1 2020$9.67B+42%SEC ↗
Q4 2019$6.81B−6%SEC ↗
Q3 2019$7.24B+3%SEC ↗
Q2 2019$7.02B+27%SEC ↗
Q1 2019$5.54B+6%SEC ↗
Q4 2018$5.21BSEC ↗

Subscribe to TheInference for free